ANZCA has endorsed a selection of guidelines developed by other organisations. Professional document A02 Policy on Endorsement of Externally Developed Guidelines articulates ANZCA's approach in this regard. Please note the relevant websites are not maintained by ANZCA.
Anaphylaxis Management Guidelines
The Australian and New Zealand Anaesthetic Allergy Group (ANZAAG), in conjunction with ANZCA, through the Anaesthetic Allergy Subcommittee of the Quality and Safety Committee, has developed anaphylaxis management guidelines. The documents are designed to be used as a crisis management package in the event of an acute perioperative anaphylaxis.
ANZAAG has a policy of continuous resource monitoring and quality improvement. Feedback from ANZCA Fellows is welcome. Changes to resources will occur in accordance with current best evidence. Please check the ANZAAG website to ensure your department is using the most up-to-date version of resources.
If you printed out the ANZAAG Anaphylaxis Management Guidelines prior to May 28, 2013 please replace the refractory management card with the June 2013 revision now available. The initial dose of IV Salbutamol in a paediatric patient should read 5 mcg/kg/min rather than 5 mcg/min.
Australian Open Disclosure Framework
The Australian Commission on Safety and Quality in Health Care has designed an open disclosure framework to enable health service organisations and clinicians to communicate openly with patients when healthcare does not go to plan.
Central Line Insertion and Maintenance Guideline
In April 2012 the Australian and New Zealand Intensive Care Society (ANZICS) published the Central Line Insertion and Maintenance Guideline. The guideline is a product of the ANZICS Central Line Associated Blood Stream Infection Prevention Project - a national quality improvement project led by ANZICS with support from the Australian Commission on Safety and Quality in Health Care.
Guidelines for Surgical Patients with Post-operative Nausea and Vomiting
These guidelines were compiled by a multidisciplinary international panel of individuals with interest and expertise in post-operative nausea and vomiting (PONV) under the auspices of the Society for Ambulatory Anesthesia. The panel members critically and systematically evaluated the current medical literature on PONV to provide an evidence-based reference tool for the management of adults and children who are undergoing surgery and are at increased risk for PONV.
Malignant Hyperthermia Crisis Management
Malignant Hyperthermia Australia and New Zealand, a group of anaesthetists and scientists with a special interest in malignant hyperthermia, have developed a resource kit. The comprehensive kit includes guidelines on resuscitation, lines and investigations, dantrolene reconstitution, cooling, logistics and other topics.
The Association of Anaesthetists of Great Britain and Ireland has released a safety guideline regarding the management of severe local anaesthetic toxicity. The guideline was produced by a working party that comprised Grant Cave, Will Harrop-Griffiths (chair), Martyn Harvey, Tim Meek, John Picard, Tim Short and Guy Weinberg. Accompanying notes are also available.
In August 2010 the Australian Commission on Safety and Quality in Health Care published National Recommendations for User-applied Labelling of Injectable Medicines, Fluids and Lines. The second edition, published in February 2012, and related resources are available here.
The commission and ANZCA have since issued a joint statement supporting user-applied labelling standardisation of injectable medicines. In addition, the commission, ANZCA and the Australian College of Operating Room Nurses have endorsed a poster demonstrating user-applied labelling of medicines and fluids in open and closed practice perioperative environments.
OSSIE Guide to Clinical Handover Improvement
The OSSIE Guide to Clinical Handover Improvement, developed by the Australian Commission on Safety and Quality in Health Care, assists with the implementation of a standardised process for handover that suits local context. It is complemented by the Implementation Toolkit for Clinical Handover Improvement, a "how to guide" for managers and clinicians reviewing local clinical handover processes.
Patient Blood Management Guidelines
The National Blood Authority is developing a series of six evidence-based patient blood management guidelines. To date, ANZCA has endorsed four modules, as follows:
- Module 1 Critical Bleeding/Massive Transfusion
- Module 2 Perioperative
- Module 3 Medical
- Module 4 Critical Care
Associate Professor Larry McNicol is a member of the Expert Working Group and chaired the Clinical/Consumer Reference Group for modules 1 and 2.
In August 2009, ANZCA welcomed the introduction of the surgical safety checklist, an important clinical tool for Australian and New Zealand hospitals. Professor Alan Merry was the principal investigator for Auckland, one of the eight pilot sites in the World Health Organization global study. ANZCA also assisted in refining the checklist, which emphasises teamwork and communication, for use in Australia and New Zealand. The checklist is not intended to be comprehensive; additions and modifications are encouraged to fit local practice and responsibilities.